Neuralgia do trigêmeo
Views: 66DOI:
https://doi.org/10.48208/HeadacheMed.2025.37Palavras-chave:
Neuralgia do trigêmeo, Dor neuropática, Compressão microvascular, NeuromodulaçãoResumo
Contexto
A neuralgia do trigêmeo (NT) é uma doença neuropática crônica caracterizada por dor facial unilateral, recorrente e intensa, na distribuição de um ou mais ramos do nervo trigêmeo.
Discussão
Embora sua prevalência seja relativamente baixa, a NT permanece uma das síndromes dolorosas mais debilitantes devido à sua intensidade e natureza imprevisível. Esta revisão tem como objetivo resumir o conhecimento atual sobre a fisiopatologia, os critérios diagnósticos e o tratamento da neuralgia do trigêmeo, incluindo opções farmacológicas e cirúrgicas.
Conclusões
A neuralgia do trigêmeo continua sendo uma condição desafiadora que requer uma abordagem individualizada e multidisciplinar.
Downloads
Referências
1. Cruccu G, Bonamico L, Zakrzewska J. Cranial neuralgias. In: Nappi G, Moskowitz M, editors. Handb Clin Neurol, vol. 97, 2010, p. 663–78. Doi:10.1016/S0072-9752(10)97056-5.
2. Tereshko Y, Dal Bello S, Lettieri C, Belgrado E, Gigli GL, Merlino G, et al. Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review. Toxins (Basel) 2024;16:500. Doi:10.3390/toxins16110500.
3. Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol 2021;21:392–402. Doi:10.1136/practneurol-2020-002782.
4. Ashina S, Robertson CE, Srikiatkhachorn A, Di Stefano G, Donnet A, Hodaie M, et al. Trigeminal neuralgia. Nat Rev Dis Primers 2024;10:39. Doi:10.1038/s41572-024-00523-z.
5. De Stefano G, Litewczuk D, Mollica C, Di Pietro G, Galosi E, Leone C, et al. Sex differences in trigeminal neuralgia: a focus on radiological and clinical characteristics. Neurological Sciences 2023;44:4465–72. Doi:10.1007/s10072-023-06923-5.
6. Sjaastad O, Fredriksen TA, Stolt-Nielsen A, Salvesen R, Jansen J, Pareja JA, et al. Cervicogenic headache: a clinical review with special emphasis on therapy. Funct Neurol 1997;12:305–17.
7. Lambru G, Rantell K, O’Connor E, Levy A, Davagnanam I, Zrinzo L, et al. Trigeminal neurovascular contact in SUNCT and SUNA: a cross-sectional magnetic resonance study. Brain 2020;143:3619–28. Doi:10.1093/brain/awaa331.
8. Lambru G, Stubberud A, Rantell K, Lagrata S, Tronvik E, Matharu MS. Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis. J Neurol Neurosurg Psychiatry 2021;92:233–41. Doi:10.1136/jnnp-2020-323999.
9. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995;45:1294–6. Doi:10.1212/WNL.45.7.1294.
10. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D’Aleo G, et al. The prevalence of pain in multiple sclerosis. Neurology 2004;63:919–21. Doi:10.1212/01.WNL.0000137047.85868.D6.
11. Pergolizzi J V., LeQuang JA, El-Tallawy SN, Wagner M, Ahmed RS, Varrassi G. An update on pharmacotherapy for trigeminal neuralgia. Expert Rev Neurother 2024;24:773–86. Doi:10.1080/14737175.2024.2365946.
12. Chow A, Haider I, Athanaselos A, Patel M. In-Hospital Management of Acute Trigeminal Neuralgia Pain Crises. Clin Med Res 2024;22:215–21. Doi:10.3121/cmr.2024.1945.
13. Muñoz-Vendrell A, Teixidor S, Sala-Padró J, Campoy S, Huerta-Villanueva M. Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases. Cephalalgia 2022;42:1031–8. Doi:10.1177/03331024221092435.
14. Mian MU, Afzal M, Butt AA, Ijaz M, Khalil K, Abbasi M, et al. Neuropharmacology of Neuropathic Pain: A Systematic Review. Cureus 2024. Doi:10.7759/cureus.69028.
15. Rana MH, Khan AAG, Khalid I, Ishfaq M, Javali MA, Baig FAH, et al. Therapeutic Approach for Trigeminal Neuralgia: A Systematic Review. Biomedicines 2023;11:2606. Doi:10.3390/biomedicines11102606.
16. Cruccu G, Di Stefano G, Truini A. Trigeminal Neuralgia. New England Journal of Medicine 2020;383:754–62. Doi:10.1056/NEJMra1914484.
17. Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol 2020;19:784–96. Doi:10.1016/S1474-4422(20)30233-7.
18. Zhao X, Ge S. The efficacy and safety of gabapentin vs. carbamazepine in patients with primary trigeminal neuralgia: A systematic review and meta-analysis. Front Neurol 2023;14. Doi:10.3389/fneur.2023.1045640.
19. Oliveira KM, Barreto ESR, Alencar VB, Lins-Kusterer LEF, Azi LMT de A, Kraychete DC. The efficacy of botulinum toxin in neuropathic pain: a systematic review. Br J Pain 2024;18:388–402. Doi:10.1177/20494637241254191.
20. Obermann M. Recent advances in understanding/managing trigeminal neuralgia. F1000Res 2019;8:505. Doi:10.12688/f1000research.16092.1.
21. Naderi Y, Rad M, Sadatmoosavi A, Khaleghi E, Khorrami Z, Chamani G, et al. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review. Clin Exp Dent Res 2024;10. Doi:10.1002/cre2.882.
22. Di Stefano G, Truini A, Cruccu G. Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. Drugs 2018;78:1433–42. Doi:10.1007/s40265-018-0964-9.
23. Gomes-da Silva de Rosenzweig P, Pastrana-Brandes S, Merikansky-Gerson S, Victoria-Garcia LO, Curtius-Caruso MS, Carrillo-Ruiz JD. Factors associated with outcomes following microvascular decompression for the treatment of primary trigeminal neuralgia in adults: a systematic review and meta-analysis. J Dent Anesth Pain Med 2024;24:227. Doi:10.17245/jdapm.2024.24.4.227.
24. Okon II, Menon SS, Osama M, Aiman M, Paleare LFF, Eliseo DL-P, et al. Microvascular decompression: a contemporary update. BMC Surg 2025;25:20. Doi:10.1186/s12893-025-02762-7.
25. McBenedict B, Hauwanga WN, Yau MCY, Pogodina A, Singh G, Abdelrahman A, et al. Outcomes of Different Surgical Interventions for Treating Trigeminal Neuralgia: A Review. Cureus 2024. Doi:10.7759/cureus.66724.
26. Khaboushan AS, Maroufi SF, Jarrah N, Moafi M, Sabahi M, Borghei-Razavi H, et al. Comparison of stereotactic radiosurgery and rhizotomy for trigeminal neuralgia: A systematic review and Meta-Analysis. Neurosurg Rev 2025;48:613. Doi:10.1007/s10143-025-03763-z.
27. Trigeminal neuralgia: therapeutic strategies to restore quality of life. J Oral Facial Pain Headache 2024. Doi:10.22514/jofph.2024.024.
28. Branco R, Silva BG, Pereira A, Amorim I, Jacinto J. What Is New and Effective in Treating Refractory Trigeminal Neuralgia? Cureus 2024. Doi:10.7759/cureus.73110.
29. Ta PCP, Dinh HQ, Nguyen K, Lin S, Ong YL, Ariyawardana A. Efficacy of gabapentin in the treatment of trigeminal neuralgia: A systematic review of randomized controlled trials. J Investig Clin Dent 2019;10. Doi:10.1111/jicd.12448.
30. Stern JI, Ali R, Chiang C-C, Robertson CE. Pathophysiology and Management of Refractory Trigeminal Neuralgia. Curr Neurol Neurosci Rep 2025;25:10. Doi:10.1007/s11910-024-01387-2.
31. Latorre G, González-García N, García-Ull J, González-Oria C, Porta-Etessam J, Molina FJ, et al. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology’s Headache Study Group. Neurología (English Edition) 2023;38:S37–52. Doi:10.1016/j.nrleng.2023.04.005.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Stephania Bohórquez-Valderrama, Maria Elena Santillán, Matias Sebastian Corzo , Carlos Federico Buonanotte , Lucas Hector Bonamico (Author)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
